Georg Seifert1,2*†
Michael Jeitler3,4†
Rainer Stange3,4Andreas Michalsen3,4
Holger Cramer5,6Benno Brinkhaus4
Tobias Esch7Annette Kerckhoff7Anna Paul5Michael Teut4
Pirus Ghadjar8Jost Langhorst9Thomas Häupl10Vijay Murthy11
Christian S. Kessler3,4- 1Department of Paediatric Oncology/Haematology, Otto-Heubner Centre for Paediatric and Adolescent Medicine (OHC), Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 2Department of Pediatrics, Faculty of Medicine, University of São Paulo, São Paulo, Brazil
- 3Department of Internal and Integrative Medicine, Immanuel Krankenhaus Berlin, Berlin, Germany
- 4Institute of Social Medicine, Epidemiology and Health Economics, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 5Department of Internal and Integrative Medicine, Evang. Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany
- 6National Centre for Naturopathic Medicine, Southern Cross University, Lismore, NSW, Australia
- 7Institute for Integrative Health Care and Health Promotion, University Clinic for Integrative Health Care, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, Germany
- 8Department of Radiation Oncology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 9Department of Internal and Integrative Medicine, Klinikum Bamberg, Chair for Integrative Medicine, University of Duisburg-Essen, Bamberg, Germany
- 10Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
- 11Faculty of Medicine, Primary Care and Population Sciences, University of Southampton, Southampton, United Kingdom
Background: During the COVID-19 pandemic people are facing risks of adverse health effects due to the restrictions implemented such as quarantine measures, reduced social contact, and self-isolation. In this qualitative review, we collected data on potential preventive and therapeutic health benefits of Complementary and Integrative Medicine (CIM) that might be useful during the COVID-19 pandemic. We have reviewed the scientific literature to summarize CIM practices that could be beneficial for improving physical and mental health and well-being of the population under the current pandemic circumstances. It must be noted that this review is not SARS-CoV-2 specific and we explicitly do not intend to make any SARS-CoV-2 specific health claims in this article.
Methods and Findings: A qualitative, non-systematic literature review was conducted in Medline to identify literature describing preventive and therapeutic CIM approaches for strengthening mental and physical health. For a variety of CIM approaches clinical evidence was identified, indicating beneficial effects. CIM approaches include specific dietary measures and selected micronutrients, physical activity, techniques from Mind-Body Medicine, single botanicals or botanical compounds, and spending time in nature among others. The effects of CIM measures on conditions like obesity and hypertension are of special relevance here, as these conditions are considered as risk factors for a severe course of COVID-19. Moreover, a possibly direct effect of CIM approaches on immune functions and clinical parameters in respiratory tract infections, such as influenza, were identified. The findings of this review could be helpful for clinicians, patients, and the general population during the current pandemic when discussing and/or considering CIM options.
Conclusions: CIM offers a variety of preventive and therapeutic options for strengthening physical and mental resilience, which could also be useful in the current COVID-19 pandemic. The evidence of CIM approaches with a potential benefit in the COVID-19 pandemic in different areas is worth to be analyzed. While this qualitative review has several obvious limitations, it might serve as useful starting point for further research on this topic.
Introduction
With the COVID-19 pandemic, mankind is facing a global health threat for which no specific therapy has yet been scientifically established. Worldwide, more than 46 million infections and 1.2 million deaths related to SARS-CoV-2 had occurred by the end of October 2020 (1). The COVID-19 pandemic as well as previous viral epi- and pandemic threats such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola virus disease and swine flu warrant the assumption that such agents will continue to threaten health care systems, societies and economies worldwide (2, 3).
Individual lifestyles not only affect overall health and well-being, but can also affect related personal risk factors to the extent that they can contribute to the spread and negative consequences of communicable diseases (CD) (4, 5). Besides, nutrition and lifestyle of individuals and populations can potentially affect environmental sustainability and human health (6). While the main focus during a pandemic such as SARS-CoV-2 is on causal factors for the virus, both the physical and mental health of individuals and the population are also important, especially for those with risk factors (7).
The most commonly identified relevant risk factors for a severe course of the COVID-19 disease in intensive care unit (ICU) patients, are hypertension (48% non-survivors vs. 23% survivors), diabetes mellitus (31 vs. 14%), coronary heart disease (24 vs. 1%), chronic obstructive pulmonary disease (7 vs. 1%), and renal dysfunction (4 vs. 0%) (7). Here, CIM approaches may mitigate the aforementioned risk factors by fostering resilience, self-efficacy/self-empowerment, and other health-related resources of the individual facing the current health challenge (8).
Although lockdowns are an important safety measure to protect public health, several cross-sectional studies showed that they can lead to a variety of negative lifestyle changes including lack of exercise, “unhealthy” eating patterns, sleep disorders, and psychological symptoms including anxiety and depression (9, 10).
The fact that a vaccine against SARS-CoV-2 or a specific cure for COVID-19 is not yet available makes it necessary to explore how current preventive and therapeutic gaps could be bridged with Complementary and Integrative Medicine (CIM) interventions. Evidence-based CIM approaches, such as Mind-Body Medicine, nutritional medicine, phytomedicine, could complement, and personalize conventional medical strategies as part of overall health care management (11, 12).
CIM practices generally emphasize a holistic, patient-centered approach to health, healthcare, and well-being—often including psycho-emotional, functional, social, and even spiritual aspects (11, 12). There is a noteworthy body of CIM knowledge that has evolved over centuries, which has been used to prevent and manage a variety of diseases and is being increasingly used in health care systems worldwide (13)—also in so-called Traditional Medicine Systems (TMS). The World Health Organization (WHO) emphasizes the role of Traditional Medicine as a medical heritage “to promote universal health coverage by integrating traditional and complementary medicine services into health care service delivery and self-health care” (14). In international scientific handling, TMS are mainly subsumed under CIM.
The complex interrelationships between the immune system and a variety of lifestyle factors such as exercise, stress reduction, healthy nutrition, spending time in nature, positive inner attitudes, and well-being have already been demonstrated (15–20). In spite of the challenges faced by people across the globe due to restrictive lifestyle factors such as social distancing and quarantine measures, the general public and patients could utilize this time of forced domestic retreat of varying degrees to strengthen resilience through simple preventive means and self-care. Thus, CIM measures could be used to improve quality of life in an extraordinary situation such as the COVID-19 crisis that causes stress, fear, anxiety and depression amongst individuals and societies worldwide (8).
The findings of this review are not intended to serve as alternative recommendations to official public health measures or conventional medical advice. They should be understood as simple and effective, preferably evidence-based tools that may complement global disease control measures and mainstream treatment strategies. At the same time, there is a worldwide tendency even among national governments, to ignore and/or reject scientific data on coronavirus and COVID-19, combined with the proliferation of related unfounded and specific health claims. Therefore, the authors explicitly want to emphasize that the results presented in this article are not SARS-CoV-2-virus specific and that no COVID-19-specific CIM claims can be made based on the current evidence-base.
Methods
A literature review in the electronic database “Medline” was carried out on July 24, 2020 and updated on October 29, 2020. Four authors (GS, MJ, AM, CK) have selected potential CIM interventions in a consensus process that could be useful in strengthening mental and physical health during the COVID-19 pandemic. Based on this the search strategy included the terms “complementary,” “integrative,” “traditional,” “medicine,” “CIM,” “CAM,” “stress,” “mind-body-medicine,” “meditation,” “yoga,” “qi gong,” “tai chi,” “phytomedicine,” “botanical medicine,” “positive wellbeing,” “optimism,” “resilience,” “virus,” “virus infection,” and “COVID-19” separately or combined by Boolean Operators. Relevant meta-analyses and original articles including prospective trials, epidemiological population-based studies and retrospective analysis, reviews and guidelines were included. Publications in English and German were included.
Results
A large variety of studies, interventions, outcomes, studied sample sizes, treatment durations, and observation times were identified. According to the studies reviewed, CIM interventions appear to strengthen physical and mental health through: (1) nutrition and vitamin supplementation, (2) Mind-Body Medicine, (3) positive attitude of life and relationships, (4) exercise, (5) nature therapy, (6) aroma therapy, (7) sleep medicine, and (8) botanicals/phytomedicine. These topics are partly covered in so-called Traditional Medicine Systems (TMS). Relevant points are presented in detail below:
Nutrition and Vitamin Supplementation
Nutrition
Nutrition is currently discussed not only as a game changer for planetary health (21) and the ongoing current climate crisis (22), but also as a potential source and reservoir for the emergence of viruses such as Ebola, MERS, SARS (23), and the development of multi-resistant bacteria (24) due to factory farming (25, 26) and wild animal markets (23). In contrast to the adverse effects of unhealthy food on health, specific diets, rich in antioxidants and anti-inflammatory nutrients, can have a significant impact with regard to disease prevention/management and longevity (27, 28).
Such an influence of nutrition on health is particularly important for older people, as eating habits that contain macro- and micronutrients as well as phytochemicals can have a positive influence on health (29). Above all nutrition can play a major role in the “individual susceptibility” to bacterial or viral infections and, if infected, in the course and outcome of the infectious disease.
Hypo- as well as hyper-caloric nutritional status, alongside certain micronutrient deficiencies have been identified as risk factors for susceptibility to infections (30). During the COVID-19 pandemic, older adults and patients with chronic diseases became particularly vulnerable and most at risk to nutrition imbalance (31). In the context of COVID-19, several position papers and suggestions for clinical investigation have been published; however, little observational data are available yet (31–34).
An optimized nutritional status can have a range of positive effects on the immune system (35). A predominantly plant-based diet, including e.g., fruits, vegetables, legumes, nuts, and olive oil, may have an influence on the susceptibility to infectious diseases; particularly foods containing potentially antimicrobial, antioxidant, anti-inflammatory, and immunomodulatory phytochemicals, such as bitter substances, vitamin C, mustard oils, herbs and spices, and herbal teas (19).
Nutrition, particularly when optimized for nutrient proportions, predominantly plant-based and organic (36), can exert relevant anti-inflammatory effects (37) and may have a long-term impact on general health and NCDs such as obesity, hypertension, and cancer (38, 39). There is growing evidence for negative correlations between plant-based nutrition, chronic inflammation (40), and pathological immune responses such as in bronchial asthma (41). A meta-analysis including 29 RCTs with 2.689 participants consumption of plant-based diets was associated with a reduction in the mean concentrations of CRP [effect size, −0.55 mg/l, 95% confidence intervals (CI): −0.78; −0.32, I2 = 94.4%] and IL-6 [effect size, −0.25 ng/l, 95% CI: −0.56; 0.06, I2 = 74%] (37).
NCDs predispose the individual to reduced immunity (40, 42), whereas enhanced nutrition protects from susceptibility to infectious agents; for example, a 5% higher proportional intake of fruit and vegetables is associated with a 12% lower hospitalization due to influenza infections (43), a lower risk of infection due to Mycobacterium tuberculosis exposure (44), and a lower frequency of urinary tract infections in pregnant women (45). Furthermore, the effectiveness of vaccination may be higher when the plant part of the diet increases (46).
In a recent systematic review, vitamins A and D showed a potential benefit in viral respiratory infections, especially in deficient populations (47). Among the trace elements, selenium and zinc have also shown beneficial immunomodulatory effects in viral respiratory infections (47). Although the nutritional status of patients with COVID-19 has not yet been adequately studied, there is preliminary evidence that nutrient-related disorders are associated with poorer disease progression and outbreak, probably associated with greater susceptibility to infection (48).
In the following, we would like to go into more detail about the vitamins D and C:
Vitamin D
Vitamin D3 has crucial influence on many functions of the immune system (49). In a randomized controlled trial (RCT) with supplementation of 400 IU/d, improvements of serum 25-hydroxyvitamin D concentrations were associated with at least a 1.5-fold alteration in the expression of 291 genes, many with relation to immune cell function and inflammatory control (50). Of potential clinical importance, vitamin D deficiency has been associated with increased prevalence of different viral conditions such as human immunodeficiency virus and hepatitis C. The role of vitamin D in influenza has remained controversial (51), although there are preventive studies that show lower incidences when supplements are given in schoolchildren (52). In this RCT Influenza A occurred in 18 of 167 (10.8%) children in the vitamin D group compared with 31 of 167 (18.6%) children in the placebo group [relative risk (RR), 0.58; 95% CI: 0.34, 0.99; P = 0.04]. A recent meta-analysis of 25 RCTs including 11.321 participants for vitamin D supplementation in respiratory tract infections, most of them assumed or proven to be viral, revealed a homogeneous risk reduction among all participants (adjusted odds ratio 0.88, 95% confidence interval 0.81–0.96; p for heterogeneity <0.001) (53).
Vitamin D3 deficiency has been shown to be a risk factor for the onset of acute respiratory distress syndrome (ARDS) (54). In the context of COVID-19 a recent retrospective population-based study in Israel showed an association between vitamin D deficiency and greater likelihood of both COVID-19 infection and hospitalization in 14,000 analyzed individuals (55). In contrast, another study analyzed data from 348.958 individuals in the United Kingdom and found no association between vitamin D levels and COVID-19 infection. Future (especially randomized) studies are warranted to clarify the effects of vitamin D supplementation in the context of COVID-19 infection.
A serum concentration of vitamin D3 (25-OH) of at least 20 ng/ml is considered to be sufficient for bone health. In a preventive setting for infectious diseases, an increased dose of 40–60 ng/mL (corr. 100–150 nmol/L) is recommended.
Vitamin C
In a systematic review of 31 RCTs with at least 0.2 g/d of orally administered vitamin C for the prevention of common colds, the incidence could not be reduced under normal conditions, some benefit was observed in the form of a reduction in the duration and/or severity of symptoms (56). However, five RCTs under conditions of unusual physical and/or thermal stress with above average performing participants demonstrated homogenous benefits with a pooled risk-ratio (RR) of 0.48 (56). This could be a model for long-term preventive use in reducing the incidence or severity of manifestation of COVID-19. Recently, a review concluded that oral vitamin C may reduce the duration of acute respiratory viral infections symptoms including fever, chest pain, chills and bodily aches and pains (57).
More recent clinical research on vitamin C has focused on higher doses, at times given intravenously, e.g., in intensive care medicine/intensive care unit (ICU). In a pooled analysis of 18 RCTs, length of ventilation, when necessary, and durations of overall stays in the ICU, mostly for cardiac reasons, were reduced (58). When shortening of ventilation was considered, eight RCTs with cardiac and septic indications gave a pooled reduction of 14% for all patients, or of 25% if ventilation was >10 h (59). In a RCT with patients with sepsis and ARDS, comparable to the situation with COVID-19 pneumonia, there was a difference in survival at day 28 of 17% in favor of vitamin C, but this was only a secondary parameter (60). On the other hand, a recently published RCT showed that treatment with intravenous vitamin C in intensive care patients with septic shock did not significantly improve the duration of time alive and free of vasopressor administration over 7 days (61). Ongoing RCTs are currently investigating the effects of intravenous high-dose vitamin C in the treatment of severe COVID-19 diseases [e.g., (62)].
Mind-Body Medicine (MBM)
MBM is based on the assumption that interactions between the brain, mind, body, and behavior can be used to activate health-promoting pathways (63). It includes behavioral approaches and techniques in conjunction with exercise, relaxation, meditation, and stress-regulation interventions (63, 64). MBM has been shown to improve psychological parameters, reduce individual and cellular stress, inflammation, improve immune function, involving epigenetic pathways, thereby facilitating self- and autoregulation, and resilience in general (65–68).
The impact of psychological and behavioral parameters on health is particularly important in vulnerable phases of life such as childhood and old age (69) or in challenging situations (70).
Psychological stress for example can lead to an increased susceptibility to viral infections of the upper airways (71). The influence of chronic stress on health is enormous (66, 72). Both CIM and stress research make a clear distinction between the effects of chronic stress and acute—but moderate—stress on health (70). Even in positively perceived stress, the dose, and duration of such stress plays an important role, since even positively evaluated permanent stress may result in health risks (70).
Several CIM interventions could be useful in the field of stress reduction in a pandemic, e.g., using mindfulness, compassion, yoga, and meditation practices (15–17). The influence of psychological processes as well as psychological and behavioral interventions on the immune system (16, 66, 73, 74), positive psychological well-being (75), physiological functions (76, 77) as well as the mind's impact on chronic diseases is quite well-researched (78).
It is known that MBM therapies can have a positive influence on inflammatory activity and virus-specific immune responses (79). A finding that may be of particular interest in the context of the current pandemic is a possibly improved antibody response through meditation in persons with chronic stress, immunocompromised persons and older adults. Antibodies were measured directly in three studies (80–82), two of which examined the antibody response to influenza vaccination (82); one showed that mindfulness-based stress reduction (MBSR) resulted in a significantly greater increase in hemagglutination-inhibition influenza antibody titers (80). The second study showed no relevant changes in serum influenza antibodies or nasal Immunoglobulin A (IgA) in older adults. In a third study in older adults with administration of the keyhole limpet hemocyanin antigen, there was a relatively larger increase in Immunoglobulin G (IgG) immediately following a MBSR intervention (81).
Literature on meditation as a method for stress reduction shows relevant potential for application in the current pandemic (76, 77). A randomized study showed that MBSR may be a novel treatment approach for reducing social risk factors like loneliness as well as like molecular pro-inflammatory gene expression in older adults (83). In general, meditation seem to have a potential for inflammation reduction, including gene expression, cellular and chromosomal health (84). This also includes self-regulation and self-healing capacities, i.e., the innate restorative capacities of mind and body (64).
In addition, several other MBM interventions showed beneficial effects. Yoga has been shown to increase several parameters of the immune function (74), as well as reduce several COVID-19 associated risk factors, including hypertension (85), obesity (86), further cardiovascular risk factors (87) or chronic obstructive pulmonary disease. Yoga and meditation are discussed in this context—also from the perspective of Traditional Indian Medicine (TIM)—as a potentially effective tool in the context of the current pandemic because of its global popularity (88–90).
Also qigong is supported by a growing body of scientific evidence (91, 92). A meta-analysis on qigong demonstrates the effectiveness of qigong in improving cardiovascular risk factors in participants with metabolic syndrome (91).
Complex MBM-trainings that include relaxation, nutritional counseling, and exercise within the framework of a multimodality group program can positively influence cardiovascular risk factors for COVID-19 such as atherosclerosis and systolic blood pressure (93).
Further studies on CIM interventions in the field of MBM are warranted in the current pandemic, possibly taught via online courses.
Positive Attitude to Life
Psychological stress has been found to lead to a significantly and dose-dependently higher infection rate with coronavirus type 229E and other seasonal pathogens (94). Emotional state may therefore be an important variable in the immune defense. A number of large epidemiological studies show the protective influence of a positive attitude toward life in chronic non-communicable diseases and further studies show that chronic stress is associated with detrimental outcomes in many health conditions (94). Positive psychological well-being does not only seem to be crucial for several cardiovascular issues, but for resilience in a broader sense (75). When life becomes meaningful and positive, it reduces the risk factors for chronic heart disease (75) and hypertension (95) by reducing high levels of stress hormones (96). A positive attitude toward life can have significant effects on survival in healthy and sick people (97). Furthermore, a positive attitude to life is associated with a lower risk of cardiovascular events and all-cause mortality (98).
Relationships
Relationships are important variables for health and survival in a variety of diseases (99). Isolation and loneliness, feelings that are likely to result from quarantine (situations) (100), which may in turn exert significant negative influence on specific physiological parameters (73, 101) such as immune functions (102) and are equally detrimental to the health as that of smoking (103). Particularly in a situation of increased insecurity such as a pandemic, where social contacts have negative connotations, strengthening social relationships (100)—possibly also via outdoor and online services can be important. In general, maintain strong relationships may lead to better objective health status and perceptions of health (99).
Exercise
The positive effects of exercise for general mental and physical health as well as for specific physiological functions including the immune system have been demonstrated in several systematic reviews and meta-analyses (18). Lack of exercise is one of the most common causes of chronic diseases, making patients more susceptible to infections and complicating disease courses (104, 105). Evidence on preventive effects of exercise for the elderly is overwhelmingly positive (106). CIM exercises offers a range of preventive possibilities that may also include MBM approaches (91, 92, 107–109). Exercise practiced in open air such as Nordic-walking or a walk in the forest may have greater overall positive effects than fitness training in a studio or indoor home situations (110, 111).
Nature and Forest Therapy
Spending time in nature can be both a preventive and a therapeutic approach that makes use of targeted effects of natural stimuli in forests, urban green spaces, and therapeutic landscapes in order to promote health-related self-regulation mechanisms in individuals and communities (15, 112). Nature and forest therapy thus represent a simple, easily accessible, low-cost, sustainable, and effective supportive method for improving health parameters. Especially in the current pandemic nature therapy can be important, because it can be practiced in the open air and individually. Therefore, these measures will most likely play an important role in preventive medicine in the near future (113). Recent studies showed an overall stress-reducing effect on quality of life, well-being, functions of the autonomic nervous system, blood pressure, endocrine activity, happiness, mental health, immune activity, and even neighborhood satisfaction (114, 115). These are factors that could be valuable in the current pandemic.
Aromatherapy
Closely related to nature and forest therapy is the field of aromatherapy. Preclinical and clinical research on the effects of certain bioactive compounds in essential oils, which are available in a large number of plants, has gained a boost and is increasingly published (116). Of particular interest are the effects of terpenes and terpenoids on the suppression of inflammatory and infection responses and the immunomodulatory properties of these compounds (117). Aromatherapy has been explicitly and/or implicitly part of CIM worldwide, particularly in the field of botanical medicine, where such properties are used to achieve specific therapeutic goals (118–120), for example to reduce anxiety (121). Due to their anti-microbial portfolio, several of these substances are of interest for the prevention of (respiratory) infections, the supportive treatment of conventional treatments, or a stand-alone CIM therapy in the case of a mild course of respiratory tract infections (122).
Sleep
Healthy sleep is undoubtedly an essential resource for health. Sleep deficiency, poor sleep quality or shifts in the chronobiologic sleep rhythm are associated with an increase in chronic diseases (123). Insufficient sleep (<7 h) is also associated with a significant increase in upper respiratory tract infections (105, 124, 125). CIM offers a variety of ways to improve sleep duration and quality including the application of oil mixtures of aromatherapy (126), e.g., lavender, but also MBSR, yoga, and tai chi may improve sleep quality (127). A small study showed that progressive muscle relaxation might reduce anxiety and improve sleep quality in patients isolated with COVID-19 (128).
Botanicals/Phytomedicine
The use of herbal substances for respiratory viral infections is widespread and there are clinical data that may be relevant during the current pandemic (8, 129). For the treatment of viral infections of the upper respiratory tract, there are many preclinical data available for individual components as well as for entire plant extracts. A selection of promising herbal medicines (Pelargonium root extract, Sambucus nigra, green Tea, Glycyrrhiza, Echinacea species, Cistus incanus, Cannabinoids) that may be relevant to the current COVID-19 pandemic are presented below. A recent meta-analysis including 7 RCTs, comprising a total of 732 adults, showed an advantage for Chinese herbal medicine (CHM) compared to standard care (SC) alone: CHM plus SC had a superior effect on the change of symptom and sign score (−1.30 by SMD, 95% CI [−2.43, −0.16]; 3 studies; n = 261, P = 0.03), on inflammatory marker C-reactive protein (CRP, mg/L; −11.82 by MD, 95% CI [−17.95, −5.69]; 5 studies; n = 325, P = 0.0002), on number of patients with improved lung CT scans (1.34 by risk ratio, 95% CI [1.19, 1.51]; 4 studies; n = 489, P < 0.00001) (130). No significant adverse events were recorded in the included RCTs. Several ongoing RCTs are investigating the effects of Chinese herbal medicine in the treatment of COVID-19.
Pelargonium Root Extract
In traditional South African medicine, the root Umckaloabo (from Pelargonium sidoides DC) has been the predominant medicine for airways infections. Use and research in Western countries have established its antibacterial and antiviral potential. When tested in several conventional assays against 14 types of viruses, it showed activity against e.g., parainfluenza virus, influenza A virus (strains H1N1 and H3N2), human coronavirus, but not against the avian influenza A virus (H5N1) (131). In another model the ciliary beat frequency increased as a factor of mucociliary clearance (132).
A systematic review of 8 RCTs using different extracts from roots of Pelargonium sidoides in a variety of upper respiratory tract infections showed moderate evidence in the treatment of acute rhinosinusitis, colds in adults and in acute bronchitis in children and adults (133). More recent reviews have confirmed this when they were limited to colds (meta-analysis of 5 RCTs) (134), and when they were limited to children and adolescents, but allowed for various respiratory infections (meta-analysis of 6 RCTs; narrative review of 8 RCTs) (135). The latter also concluded symptom-alleviating effects in special situations such as in asthmatic or immunocompromised children (136).
Sambucus Nigra
For centuries, TMS in Europe and North America have used black elderberry (Sambucus nigra L.) for colds and influenza. In-vitro activity against 18 strains of influenza was shown with a syrup (137), while infected chimpanzees had better recovery from influenza (138). In contrast to many other phytodrugs, Sambucus nigra was already tested in at least two placebo-controlled RCTs in times when no standard antiviral therapy was available. They differed by about one decade and locations (Israel and Norway, respectively), so different influenza strains were predominant. The results were very similar, as the relief of self-reported symptoms was accelerated by an average of 4 days. In both studies, syrup with a standardized content of flavonoids, which was considered to be the active ingredient, was administered (139, 140).
Green Tea
Catechins as a class of polyphenolic flavonoids are the main active ingredients of green tea as well as many other teas, which among other properties can strengthen the immunity against viral, especially influenza infections (141). The most prominent of these, epigallocatechin gallate (EGCG), even inhibited dengue virus infection in vitro regardless of the serotype and at concentrations reasonable for pharmacological application (142). Several epidemiological studies have suggested that regular consumption of green tea decreases influenza infection rates (143), while clinical trials have mostly used standardized catechin extracts. In one study, a cohort of low-risk health professionals took 1,000 mg/d of standardized green tea catechins or placebo over 150 days. The incidence of viral influenza was lowered by an odds ratio of 0.25, at the same time duration of symptoms was shorter (144).
In addition to optimizing systemic immune functions, experiments have been carried out to investigate the effects of gargling green tea to protect against the influenza virus at the point of first contact with the human mucosa in the throat. The pooled analysis of 5 RCTs gave a relative risk of 0.7 for the incidence of influenza for green tea gargling as compared with water gargling or no intervention (145).
Glycyrrhiza
Due to the lack of effective antiviral drugs, several phytodrugs have been used for antiviral indications, mostly in prevention and/or treatment of influenza and common cold (146). The saponin glycyrrhizin either from Glycyrrhiza glabra (Mediterranean world) or from Glycyrrhiza uralensis Fisher (Eastern Asia) is considered to be the active component of licorice roots used almost all over the world. Its immunomodulatory and anti-inflammatory effects are well-known. Mice infected with lethal doses of influenza virus had much better chances of survival after having been given glycyrrhizin (147). Uptake of influenza A virus into isolated human lung cells and its intracellular replication were clearly reduced, but only when the glycyrrhizin was given before infection (148). In spite of its frequently recommended use, it has been tested in RCTs only as one of four components of maoto, the most frequent formulation for influenza in the traditional Japanese medicine “Kampo.” According to a systematic review, it may decrease the duration of fever when used alone or in combination with standard neuroaminidase inhibitor therapies (149).
Echinacea Species
Numerous preparations of different parts and with different extracts of Echinacea species, esp. purpurea L. and angustifolia L. have been used for similar purposes as glycyrrhizin. A Cochrane review revealed small advantages in reducing incidence and course of common cold (150). A whole-plant hydroethanolic extract from freshly pressed Echinacea purpurea was given in an RCT to patients with proven influenza and was not inferior to standard therapy with oseltamivir (151). A recent review showed that study results were largely consistent with a decrease in pro-inflammatory cytokines that play a role in the progression of cytokine storm and ARDS. No studies are currently being conducted on the therapeutic effect of echinacea in the treatment of cytokine storm (152).
Cistus Incanus
In recent studies, promising anti-viral properties of the traditional Mediterranean medicinal plant Cistus incanus (or Cistus creticus) containing highly polymeric polyphenols as active ingredients were established in preclinical (153) and animal studies (154) in influenza models. However, clinical efficacy could only be shown in one RCT with common cold (155).
Cannabinoids
Recently, with reference to the “cytokine storm” associated to COVID-19, certain cannabinoids have also been discussed as potentially useful in this context, based on immunomodulatory properties associated to cannabinoids; however, the available evidence is exclusively from the preclinical area and does not allow any conclusions regarding potential effects of cannabinoids in the context of acute viral infections (156).
Traditional Medicine Systems (TMS)
Many of the above presented aspects can be found as part of TMS. TMS have a vast and diverse heritage from across the world and the WHO defines TMS as an “essential resource in medical care” (14).
At present, the majority of Chinese COVID-19 patients are treated with Traditional Chinese Medicine (TCM) in addition to conventional medicine within the framework of official medical therapy strategies (157–159). Similar developments are currently evolving in India with Traditional Indian Medicine (TIM) as well (88, 90, 160).
The main mechanisms of action of TMS-based self-regulatory approaches are mainly attributed to changes in diet and lifestyle under preventive aspects (161). But TMS may also offer a variety of defined supportive treatment measures for infectious diseases, such as poly-herbal compound preparations (157, 158, 162). Their effects are usually much more unspecific than, for example, a targeted antiviral strategy tailored to individual virus subtypes. The non-specificity of TMS may indeed prove to be of advantage, for a broader universal applicability with fewer adverse effects.
There are a number of protocols for systematic reviews and meta-analyses in the field of TCM on various topics related to COVID-19 associated diseases, the results of which are to be published in the coming months (163–167). On the other hand TCM may include products from rare wildlife, thus TCM could act as a source of SARS-CoV-2 like novel viruses (168). In response to the rapid spread of SARS-CoV-2 and the assumed role of Chinese wildlife markets, the Chinese government issued a temporary ban on the hunting, trade, and consumption of numerous wildlife species in February 2020 (169). However, these measures affect only part of the wildlife trade: the government defined only certain wild animals as “special farm animals,” thus exempting them from the trade ban (170). The wildlife ban only applies to consumption, but not to use in TCM (169); this does not account for the largely vegetarian-oriented TMS of South Asia, for example Ayurveda (171).
General Recommendations
We have assembled a compendium of CIM recommendations formulated for clinicians, patients and the healthy population for general use, but these recommendations might be of particular benefit to people during the current COVID-19 pandemic (Figure 1 and Table 1).
Figure 1. Key aspects of CIM in strengthening mental and physical health during a pandemic.
Table 1. Recommendations for patients.
Discussion
The aim of this qualitative review was to summarize the available evidence of CIM approaches with potential preventive and/or therapeutic relevance to the current COVID-19 pandemic. No SARS-CoV-2 specific claims are being made. Based on the available data, CIM could support coping strategies that could be helpful in dealing with the potential impact of public restriction measures imposed by the pandemic on the health and well-being of individuals and communities.
The relevance of CIM approaches in the COVID-19 pandemic is based mainly on the following four aspects: (1) CIM can have favorable effects on risk factors through lifestyle modifications such as diet, stress reduction, exercise, and other means of self-care (8, 158, 161), (2) CIM and especially MBM interventions can have a positive effect on stress and psychological parameters in a pandemic situation, particularly in the context of social isolation, anxiety, and depression (100), (3) CIM can strengthen the immune system in the case of non-communicable diseases (NCD) and CD (173), (4) CIM may have antimicrobial effects in case of targeted nutritional interventions and selected phytomedicine (8). The fact that the mentioned approaches and their mechanisms of action are not (yet) specific for SARS-CoV-2 and COVID-19 is not a convincing argument against the use of selected CIM measures in this global crisis. When few scientific data on effective and pathogen- and disease-specific preventive or therapeutic choices are available, considering CIM tools may be a wise response in our call for action during this pandemic.
Currently, no specific therapy for COVID-19 has shown to be effective that has been tested in at least one convincing RCT. Even for initially promising drugs, the evidence so far is negative (Hydroxychloroquine) or ambivalent (Remdesevir), while worldwide research in this field are developing with incredible urgency (174). In addition, proven preventive strategies are limited to an inhibition of any contact that facilitates virus transfer (175). Specific population groups at particular risk are the elderly, and patients suffering from COVID-19 with comorbidities such as chronic diseases like hypertension, diabetes, lung diseases, cancer, rheumatism, or autoimmune diseases. These population groups need strategies to cope with the current crisis (7). There is no proven or recommended strategy for people at risk to decrease their susceptibility, or if infected improve course and outcome (33). In addition, effective rehabilitation measures will be required for COVID-19 intensive care survivors. Here as well, it is important to identify specific and non-specific measures as well as their possible additive contributions from the fields like nutrition, physical exercise, phytomedicine, TMS, and MBM.
Another aim should be to improve immune functions through sufficient availability of essential micronutrients to build defense and physiological coping mechanisms, and to increase regenerative functions. CIM approaches may be a way to attempt delaying virus replication in the case of infection e.g., with the aid of selected foods for which antiviral effects have been demonstrated experimentally, though yet not for SARS-CoV-2, or which may indirectly improve the immune defense by reducing pathogens in other mucous membranes (such as the intestine) since there many food compounds with potential antiviral properties exist. Several different nutrients and vitamin compounds and applications have been found to improve and clean mucosal surfaces, thus interfering with viral replication on the mucosal surface and improving tissue homeostasis during viral replication and immune defense (132). For example, vitamin C is particularly important in the metabolism of immune cells and, as an antioxidant, is providing protection against collateral damage to cells and tissues caused by oxygen radicals as part of the immune defense. Regenerative processes in building and maintaining connective tissue structures are also improved by vitamin C, an effect that is gradually lost in scurvy, the vitamin C deficiency disease (176).
As previously discussed, many of the CIM measures may have the greatest effect in the field of prevention and strengthening of coping mechanisms as well as reduce risk factors for severe COVID-19 courses. However, CIM interventions could also help in the situation of acute infections. For example, many of the described substances are probably most effective when in direct contact with the pathogen in sufficient concentration already when consumed, such as when they can act as tea in the mouth and the throat area (e.g., gargling with green tea), when they act on the intestinal mucosa during digestion or when they are released back to respiratory surfaces from the circulation after absorption through the gut mucosa (e.g., garlic, ginger, thyme). A significant positive effect of these foods could also be their effect on the intestinal flora. The microbiome of the intestine is strongly influenced by our diet. Particularly with poor nutrition (rich in refined sugar, saturated fatty acids, animal protein, fried and processed foods), the burden by increased scavenging processes for macrophages and the stress to microbial metabolite removal for the immune system can weaken the defense capacity in acute infections. Therefore, a healthy, preferably plant-based diet could be of additional importance as a basic component of prevention (177–179).
Limitations of this non-systematic qualitative review include (1) presentation of CIM interventions and substances to the largest extend not (yet) tested on COVID-19 patients, (2) uncertainty about the safety of such interventions in case of COVID-19 infections, (3) uncertainty about which CIM intervention might be most appropriate for the individual patient, and (4) a non-systematic selection of CIM interventions. Thus, publication biases could not be excluded. In addition, most reported meta-analyses reported a very low to moderate quality of evidence. Following reviews and clinical studies should therefore systematically assess the safety of CIM interventions, conduct methodologically high-quality CIM studies in prevention and therapy of COVID-19 patient symptoms and systematically review present and further CIM interventions.
Conclusion
During the current COVID-19 pandemic, robust evidence for effective prevention and specific therapy at the global level is not yet available. To date, there is no clinical evidence of a CIM measure to prevent or treat SARS-CoV-2-infection. Nevertheless, action must now be taken to reduce the potential negative impact of quarantine and physical distancing on human well-being and to reduce the morbidity and mortality of COVID-19 (180). CIM holds a substantial potential for building resilience and strengthening preventative resources through measures such as changing lifestyle and diet, using herbs, improving mental and physical health and reducing stress. In particular the fields of botanical medicine and aromatherapy should be subjects of further scientific attention and clinical research, as it is known from substantial preclinical and limited clinical research that many botanicals have properties that protect against respiratory viruses.
CIM offers a variety of easily feasible, accessible, evidence-based preventive, and therapeutic options for respiratory infections and for strengthening physical and mental resilience, likely to also help in prevention and treatment of COVID-19. An increased and sustaining use of the preventive and therapeutic potential of CIM in addition to the development of vaccination and specific treatment strategies for COVID-19 seems plausible and necessary. Although the amount of literature on CIM topics is steadily increasing, this does not necessarily correspond to an increase in high-quality evidence. Particularly, further clinical research is needed, including methodologically high-quality studies. Reviews should be continuously updated to provide a balanced view of the available data. In summary, more scientific work needs to be done to clarify the use of CIM interventions in the prevention and treatment of COVID-19. However, the implementation of potentially effective, safe and easily accessible CIM measures should already be considered now. In addition, there is a need to identify unsubstantiated claims of CIM measures with respect to SARS-CoV-2. All this would require a national or supranational initiative to facilitate the necessary substantial research to define possible contributions of CIM in the COVID-19 pandemic and beyond.
Author Contributions
GS and CK conceived the manuscript, gathered information, and wrote part of the paper. MJ, RS, AM, HC, BB, TE, AK, AP, MT, PG, JL, TH, and VM gathered information and wrote part of the paper. All authors contributed to the article and approved the submitted version.
Funding
We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité – Universitätsmedizin Berlin.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. University JH. Johns Hopkins University (2020). Available online at: https://coronavirus.jhu.edu/map.html (assessed October 31, 2020).
2. National Academies of Sciences Engineering and Medicine. Exploring Lessons Learned from a Century of Outbreaks: Readiness for 2030: Proceedings of a Workshop. Washington, DC: The National Academies Press (2019). doi: 10.17226/25391
3. Pike J, Bogich T, Elwood S, Finnoff DC, Daszak P. Economic optimization of a global strategy to address the pandemic threat. Proc Natl Acad Sci USA. (2014) 111:18519–23. doi: 10.1073/pnas.1412661112
4. Di Marco M, Baker ML, Daszak P, De Barro P, Eskew EA, Godde CM, et al. Opinion: sustainable development must account for pandemic risk. Proc Natl Acad Sci USA. (2020) 117:3888–92. doi: 10.1073/pnas.2001655117
5. Keesing F, Belden LK, Daszak P, Dobson A, Harvell CD, Holt RD, et al. Impacts of biodiversity on the emergence and transmission of infectious diseases. Nature. (2010) 468:647–52. doi: 10.1038/nature09575
6. Tilman D, Clark M. Global diets link environmental sustainability and human health. Nature. (2014) 515:518–22. doi: 10.1038/nature13959
7. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054–62. doi: 10.1016/s0140-6736(20)30566-3
8. Alschuler L, Weil A, Horwitz R, Stamets P, Chiasson AM, Crocker R, et al. Integrative considerations during the COVID-19 pandemic. Explore. (2020) 16:354–6. doi: 10.1016/j.explore.2020.03.007
9. Constant A, Conserve DF, Gallopel-Morvan K, Raude J. Socio-cognitive factors associated with lifestyle changes in response to the COVID-19 epidemic in the general population: results from a cross-sectional study in France. Front Psychol. (2020) 11:579460. doi: 10.3389/fpsyg.2020.579460
10. Cheikh Ismail L, Osaili TM, Mohamad MN, Al Marzouqi A, Jarrar AH, Abu Jamous DO, et al. Eating habits and lifestyle during COVID-19 lockdown in the United Arab Emirates: a cross-sectional study. Nutrients. (2020) 12:E3314. doi: 10.3390/nu12113314
11. Maizes V, Rakel D, Niemiec C. Integrative medicine and patient-centered care. Explore. (2009) 5:277–89. doi: 10.1016/j.explore.2009.06.008
12. Bell IR, Caspi O, Schwartz GE, Grant KL, Gaudet TW, Rychener D, et al. Integrative medicine and systemic outcomes research: issues in the emergence of a new model for primary health care. Arch Intern Med. (2002) 162:133–40. doi: 10.1001/archinte.162.2.133
13. Abrams D. I Integrative medicine in America. Glob Adv Health Med. (2012) 1:10–2. doi: 10.7453/gahmj.2012.1.3.002
14. World Health Organization. WHO Traditional Medicine Strategy 2014-2023. (2019). Available online at: https://www.who.int/health-topics/traditional-complementary-and-integrative-medicine#tab=tab_2
15. Kuo M. How might contact with nature promote human health? Promising mechanisms and a possible central pathway. Front Psychol. (2015) 6:1093. doi: 10.3389/fpsyg.2015.01093
16. Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. (2016) 1373:13–24. doi: 10.1111/nyas.12998
17. Pace TW, Negi LT, Adame DD, Cole SP, Sivilli TI, Brown TD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology. (2009) 34:87–98. doi: 10.1016/j.psyneuen.2008.08.011
18. Woods JA, Davis JM, Smith JA, Nieman DC. Exercise and cellular innate immune function. Med Sci Sports Exerc. (1999) 31:57–66. doi: 10.1097/00005768-199901000-00011
19. Gershwin ME, German JB, Keen CL. Nutrition and Immunology: Principles and Practice. Berlin: Springer Science & Business Media (1999).
20. Dinu M, Abbate R, Gensini GF, Casini A, Sofi F. Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr. (2017) 57:3640–9. doi: 10.1080/10408398.2016.1138447
21. Willett W, Rockstrom J, Loken B, Springmann M, Lang T, Vermeulen S, et al. Food in the anthropocene: the EAT-Lancet commission on healthy diets from sustainable food systems. Lancet. (2019) 393:447–92. doi: 10.1016/S0140-6736(18)31788-4
22. Smith KF, Goldberg M, Rosenthal S, Carlson L, Chen J, Chen C, et al. Global rise in human infectious disease outbreaks. J R Soc Interface. (2014) 11:20140950. doi: 10.1098/rsif.2014.0950
23. Nelson MI, Viboud C, Vincent AL, Culhane MR, Detmer SE, Wentworth DE, et al. Global migration of influenza A viruses in swine. Nat Commun. (2015) 6:6696. doi: 10.1038/ncomms7696
24. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. (2016) 14:523–34. doi: 10.1038/nrmicro.2016.81
25. Dhingra MS, Artois J, Dellicour S, Lemey P, Dauphin G, Von Dobschuetz S, et al. Geographical and historical patterns in the emergences of novel Highly Pathogenic Avian Influenza (HPAI) H5 and H7 viruses in poultry. Front Vet Sci. (2018) 5:84. doi: 10.3389/fvets.2018.00084
26. Hafez HM, Attia YA. Challenges to the poultry industry: current perspectives and strategic future after the COVID-19 outbreak. Front Vet Sci. (2020) 7:516. doi: 10.3389/fvets.2020.00516
27. Fontana L, Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell. (2015) 161:106–18. doi: 10.1016/j.cell.2015.02.020
28. Martini D. Health benefits of mediterranean diet. Nutrients. (2019) 11:1802. doi: 10.3390/nu11081802
29. Talegawkar SA, Bandinelli S, Bandeen-Roche K, Chen P, Milaneschi Y, Tanaka T, et al. A higher adherence to a Mediterranean-style diet is inversely associated with the development of frailty in community-dwelling elderly men and women. J Nutr. (2012) 142:2161–6. doi: 10.3945/jn.112.165498
30. Redel H, Siegel PB. Nutrition, immunity and infection. In: Gerald L. Mandell JEB, Raphael D, editors. Principles and Practice of Infectious Diseases. 2nd ed. Philadelphia, PA: Elsevier (2019). p. 4328.
31. Naja F, Hamadeh R. Nutrition amid the COVID-19 pandemic: a multi-level framework for action. Eur J Clin Nutr. (2020) 74:1117–21. doi: 10.1038/s41430-020-0634-3
32. Barazzoni R, Bischoff SC, Breda J, Wickramasinghe K, Krznaric Z, Nitzan D, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. (2020) 39:1631–8. doi: 10.1016/j.clnu.2020.03.022
33. Gasmi A, Noor S, Tippairote T, Dadar M, Menzel A, Bjorklund G. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clin Immunol. (2020) 215:108409. doi: 10.1016/j.clim.2020.108409
34. Alagawany M, Attia Y, Farag M, Elnesr S, Nagadi S, Shafi M, et al. The strategy of boosting the immune system under CoViD-19 pandemic. Front Vet Sci. (in press). doi: 10.3389/fvets.2020.570748
35. Alwarawrah Y, Kiernan K, MacIver NJ. Changes in nutritional status impact immune cell metabolism and function. Front Immunol. (2018) 9:1055. doi: 10.3389/fimmu.2018.01055
36. Mie A, Andersen HR, Gunnarsson S, Kahl J, Kesse-Guyot E, Rembialkowska E, et al. Human health implications of organic food and organic agriculture: a comprehensive review. Environ Health. (2017) 16:111. doi: 10.1186/s12940-017-0315-4
37. Eichelmann F, Schwingshackl L, Fedirko V, Aleksandrova K. Effect of plant-based diets on obesity-related inflammatory profiles: a systematic review and meta-analysis of intervention trials. Obes Rev. (2016) 17:1067–79. doi: 10.1111/obr.12439
38. Casas R, Sacanella E, Estruch R. The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocr Metab Immune Disord Drug Targets. (2014) 14:245–54. doi: 10.2174/1871530314666140922153350
39. James PT, Ali Z, Armitage AE, Bonell A, Cerami C, Drakesmith H, et al. Could nutrition modulate COVID-19 susceptibility and severity of disease? A systematic review. medRxiv [Preprint]. (2020). doi: 10.1101/2020.10.19.20214395
40. Ley SH, Sun Q, Willett WC, Eliassen AH, Wu K, Pan A, et al. Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women. Am J Clin Nutr. (2014) 99:352–60. doi: 10.3945/ajcn.113.075663
41. Hosseini B, Berthon BS, Wark P, Wood LG. Effects of fruit and vegetable consumption on risk of asthma, wheezing and immune responses: a systematic review and meta-analysis. Nutrients. (2017) 9:341. doi: 10.3390/nu9040341
42. Hwang JH, Lee JK, Kim TJ, Kim MK. The association between fruit and vegetable consumption and HPV viral load in high-risk HPV-positive women with cervical intraepithelial neoplasia. Cancer Causes Control. (2010) 21:51–9. doi: 10.1007/s10552-009-9433-9
43. Charland KM, Buckeridge DL, Hoen AG, Berry JG, Elixhauser A, Melton F, et al. Relationship between community prevalence of obesity and associated behavioral factors and community rates of influenza-related hospitalizations in the United States. Influenza Other Respir Viruses. (2013) 7:718–28. doi: 10.1111/irv.12019
44. Fox GJ, Lee RS, Lucas M, Khan FA, Proulx JF, Hornby K, et al. Inadequate diet is associated with acquiring Mycobacterium tuberculosis infection in an Inuit community a case-control study. Ann Am Thorac Soc. (2015) 12:1153–62. doi: 10.1513/AnnalsATS.201503-156OC
45. Li L, Werler MM. Fruit and vegetable intake and risk of upper respiratory tract infection in pregnant women. Public Health Nutr. (2010) 13:276–82. doi: 10.1017/S1368980009990590
46. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. (2012) 335:936–41. doi: 10.1126/science.1214935
47. Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Enhancing immunity in viral infections, with special emphasis on COVID-19: a review. Diabetes Metab Syndr. (2020) 14:367–82. doi: 10.1016/j.dsx.2020.04.015
48. Fedele D, De Francesco A, Riso S, Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: an overview. Nutrition. (2020) 81:111016. doi: 10.1016/j.nut.2020.111016
49. Schwalfenberg GK. A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res. (2011) 55:96–108. doi: 10.1002/mnfr.201000174
50. Hossein-nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS ONE. (2013) 8:e58725. doi: 10.1371/journal.pone.0058725
51. Gruber-Bzura BM. Vitamin D and influenza-prevention or therapy? Int J Mol Sci. (2018) 19:2419. doi: 10.3390/ijms19082419
52. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. (2010) 91:1255–60. doi: 10.3945/ajcn.2009.29094
53. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. (2017) 356:i6583. doi: 10.1136/bmj.i6583
54. Dancer RC, Parekh D, Lax S, D'Souza V, Zheng S, Bassford CR, et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS). Thorax. (2015) 70:617–24. doi: 10.1136/thoraxjnl-2014-206680
55. Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. (2020) 287:3693–702. doi: 10.1111/febs.15495
56. Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. (2013) CD000980. doi: 10.1002/14651858.CD000980.pub4
57. Schloss J, Lauche R, Harnett J, Hannan N, Brown D, Greenfield T, et al. Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: a rapid review. Adv Integr Med. (2020) 7:187–91. doi: 10.1016/j.aimed.2020.07.008
58. Hemilä H, Chalker E. Vitamin C can shorten the length of stay in the ICU: a meta-analysis. Nutrients. (2019) 1:708. doi: 10.3390/nu11040708
59. Hemilä H, Chalker E. Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis. J Intensive Care. (2020) 8:15. doi: 10.1186/s40560-020-0432-y
60. Fowler AA 3rd, Fisher BJ, Kashiouris MG. Vitamin C for sepsis and acute respiratory failure-reply. JAMA. (2020) 323:792–3. doi: 10.1001/jama.2019.21987
61. Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. (2020) 323:423–31. doi: 10.1001/jama.2019.22176
62. Liu F, Zhu Y, Zhang J, Li Y, Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial. BMJ Open. (2020) 10:e039519. doi: 10.1136/bmjopen-2020-039519
63. Dusek JA, Benson H. Mind-body medicine: a model of the comparative clinical impact of the acute stress and relaxation responses. Minn Med. (2009) 92:47–50.
64. Esch T. Self-healing in health-care: using the example of mind-body medicine. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. (2020) 63:577–85. doi: 10.1007/s00103-020-03133-8
65. Black DS, Christodoulou G, Cole S. Mindfulness meditation and gene expression: a hypothesis-generating framework. Curr Opin Psychol. (2019) 28:302–6. doi: 10.1016/j.copsyc.2019.06.004
66. Bottaccioli AG, Bottaccioli F, Minelli A. Stress and the psyche-brain-immune network in psychiatric diseases based on psychoneuroendocrineimmunology: a concise review. Ann N Y Acad Sci. (2019) 1437:31–42. doi: 10.1111/nyas.13728
67. Cathomas F, Murrough JW, Nestler EJ, Han MH, Russo SJ. Neurobiology of resilience: interface between mind and body. Biol Psychiatry. (2019) 86:410–20. doi: 10.1016/j.biopsych.2019.04.011
68. Stefano GB, Esch T, Kream RM. Augmentation of whole-body metabolic status by mind-body training: synchronous integration of tissue- and organ-specific mitochondrial function. Med Sci Monitor Basic Res. (2019) 25:8–14. doi: 10.12659/msmbr.913264
69. Dinan TG, Cryan JF. Microbes, immunity, and behavior: psychoneuroimmunology meets the microbiome. Neuropsychopharmacology. (2017) 42:178–92. doi: 10.1038/npp.2016.103
70. Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. (2014) 58:193–210. doi: 10.1007/s12026-014-8517-0
71. Pedersen A, Zachariae R, Bovbjerg DH. Influence of psychological stress on upper respiratory infection–a meta-analysis of prospective studies. Psychosom Med. (2010) 72:823–32. doi: 10.1097/PSY.0b013e3181f1d003
72. Nagaraja AS, Sadaoui NC, Dorniak PL, Lutgendorf SK, Sood AK. SnapShot: stress and disease. Cell Metab. (2016) 23:388.e1. doi: 10.1016/j.cmet.2016.01.015
73. Cruces J, Venero C, Pereda-Perez I, De la Fuente M. The effect of psychological stress and social isolation on neuroimmunoendocrine communication. Curr Pharm Des. (2014) 20:4608–28. doi: 10.2174/1381612820666140130205822
74. Falkenberg RI, Eising C, Peters ML. Yoga and immune system functioning: a systematic review of randomized controlled trials. J Behav Med. (2018) 41:467–82. doi: 10.1007/s10865-018-9914-y
75. Boehm JK, Kubzansky LD. The heart's content: the association between positive psychological well-being and cardiovascular health. Psychol Bull. (2012) 138:655–91. doi: 10.1037/a0027448
76. Gallegos AM, Crean HF, Pigeon WR, Heffner KL. Meditation and yoga for posttraumatic stress disorder: a meta-analytic review of randomized controlled trials. Clin Psychol Rev. (2017) 58:115–24. doi: 10.1016/j.cpr.2017.10.004
77. Pascoe MC, Thompson DR, Jenkins ZM, Ski CF. Mindfulness mediates the physiological markers of stress: systematic review and meta-analysis. J Psychiatric Res. (2017) 95:156–78. doi: 10.1016/j.jpsychires.2017.08.004
78. Caes L, Orchard A, Christie D. Connecting the mind-body split: understanding the relationship between symptoms and emotional well-being in chronic pain and functional gastrointestinal disorders. Healthcare. (2017) 5:93. doi: 10.3390/healthcare5040093
79. Morgan N, Irwin MR, Chung M, Wang C. The effects of mind-body therapies on the immune system: meta-analysis. PLoS ONE. (2014) 9:e100903. doi: 10.1371/journal.pone.0100903
80. Hayney MS, Coe CL, Muller D, Obasi CN, Backonja U, Ewers T, et al. Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial. Hum Vaccin Immunother. (2014) 10:83–91. doi: 10.4161/hv.26661
81. Moynihan JA, Chapman BP, Klorman R, Krasner MS, Duberstein PR, Brown KW, et al. Mindfulness-based stress reduction for older adults: effects on executive function, frontal alpha asymmetry and immune function. Neuropsychobiology. (2013) 68:34–43. doi: 10.1159/000350949
82. Davidson RJ, Kabat-Zinn J, Schumacher J, Rosenkranz M, Muller D, Santorelli SF, et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosom Med. (2003) 65:564–70. doi: 10.1097/01.psy.0000077505.67574.e3
83. Creswell JD, Irwin MR, Burklund LJ, Lieberman MD, Arevalo JM, Ma J, et al. Mindfulness-based stress reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun. (2012) 26:1095–101. doi: 10.1016/j.bbi.2012.07.006
84. Esch T, Kream RM, Stefano GB. Chromosomal processes in mind-body medicine: chronic stress, cell aging, and telomere length. Med Sci Monitor Basic Res. (2018) 24:134–40. doi: 10.12659/msmbr.911786
85. Cramer H, Haller H, Lauche R, Steckhan N, Michalsen A, Dobos G. A systematic review and meta-analysis of yoga for hypertension. Am J Hypertens. (2014) 27:1146–51. doi: 10.1093/ajh/hpu078
86. Lauche R, Langhorst J, Lee MS, Dobos G, Cramer H. A systematic review and meta-analysis on the effects of yoga on weight-related outcomes. Prevent Med. (2016) 87:213–32. doi: 10.1016/j.ypmed.2016.03.013
87. Cramer H, Lauche R, Haller H, Steckhan N, Michalsen A, Dobos G. Effects of yoga on cardiovascular disease risk factors: a systematic review and meta-analysis. Int J Cardiol. (2014) 173:170–83. doi: 10.1016/j.ijcard.2014.02.017
88. Tillu G, Chaturvedi S, Chopra A, Patwardhan B. Public health approach of ayurveda and yoga for COVID-19 prophylaxis. J Alternat Complement Med. (2020) 26:360–4. doi: 10.1089/acm.2020.0129
89. Bushell W, Castle R, Williams MA, Brouwer KC, Tanzi RE, Chopra D, et al. Meditation and yoga practices as potential adjunctive treatment of SARS-CoV-2 infection and COVID-19: a brief overview of key subjects. J Alternat Complement Med. (2020) 26:547–56. doi: 10.1089/acm.2020.0177
90. Payyappallimana U, Patwardhan K, Mangalath P, Kessler CS, Jayasundar R, Kizhakkeveettil A, et al. The COVID-19 pandemic and the relevance of ayurveda's whole systems approach to health and disease management. J Alternat Complement Med. (2020). doi: 10.1089/acm.2020.0370. [Epub ahead of print].
91. Zou L, Zhang Y, Sasaki JE, Yeung AS, Yang L, Loprinzi PD, et al. Wuqinxi qigong as an alternative exercise for improving risk factors associated with metabolic syndrome: a meta-analysis of randomized controlled trials. Int J Environ Res Public Health. (2019) 16:1396. doi: 10.3390/ijerph16081396
92. Guo L, Kong Z, Zhang Y. Qigong-based therapy for treating adults with major depressive disorder: a meta-analysis of randomized controlled trials. Int J Environ Res Public Health. (2019) 16:826. doi: 10.3390/ijerph16050826
93. Cramer H, Lauche R, Paul A, Langhorst J, Michalsen A, Dobos G. Mind-body medicine in the secondary prevention of coronary heart disease. Deutsches Arzteblatt Int. (2015) 112:759–67. doi: 10.3238/arztebl.2015.0759
94. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. (1991) 325:606–12.
95. Trudel-Fitzgerald C, Boehm JK, Kivimaki M, Kubzansky LD. Taking the tension out of hypertension: a prospective study of psychological well being and hypertension. J Hypertens. (2014) 32:1222–8. doi: 10.1097/hjh.0000000000000175
96. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull. (1996) 119:488–531. doi: 10.1037/0033-2909.119.3.488
97. Chida Y, Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom Med. (2008) 70:741–56. doi: 10.1097/PSY.0b013e31818105ba
98. Rozanski A, Bavishi C, Kubzansky LD, Cohen R. Association of optimism with cardiovascular events and all-cause mortality: a systematic review and meta-analysis. JAMA Netw Open. (2019) 2:e1912200. doi: 10.1001/jamanetworkopen.2019.12200
99. Shah SB, Barsky AJ, Vaillant G, Waldinger RJ. Childhood environment as a predictor of perceived health status in late life. Health Psychol Res. (2014) 2:1560. doi: 10.4081/hpr.2014.1560
100. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. (2020) 395:912–20. doi: 10.1016/s0140-6736(20)30460-8
101. Campagne DM. Stress and perceived social isolation (loneliness). Arch Gerontol Geriatr. (2019) 82:192–9. doi: 10.1016/j.archger.2019.02.007
102. Kopec AM, Smith CJ, Bilbo SD. Neuro-immune mechanisms regulating social behavior: dopamine as mediator? Trends Neurosci. (2019) 42:337–48. doi: 10.1016/j.tins.2019.02.005
103. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. (2010) 7:e1000316. doi: 10.1371/journal.pmed.1000316
104. Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary behavior, exercise, and cardiovascular health. Circ Res. (2019) 124:799–815. doi: 10.1161/circresaha.118.312669
105. Shibata M, Iwane T, Higuchi R, Suwa K, Nakajima K. Potential common factors associated with predisposition to common cold in middle-aged and elderly Japanese: a community-based cross-sectional study. Medicine. (2018) 97:e10729. doi: 10.1097/md.0000000000010729
106. Mora JC, Valencia WM. Exercise and older adults. Clin Geriatr Med. (2018) 34:145–62. doi: 10.1016/j.cger.2017.08.007
107. Carlson LE. Distress management through mind-body therapies in oncology. J Natl Cancer Instit Monogr. (2017) 52:37–40. doi: 10.1093/jncimonographs/lgx009
108. Chan JSY, Deng K, Wu J, Yan JH. Effects of meditation and mind-body exercises on older adults' cognitive performance: a meta-analysis. Gerontologist. (2019) 59:e782–90. doi: 10.1093/geront/gnz022
109. Chiu HY, Chiang PC, Miao NF, Lin EY, Tsai PS. The effects of mind-body interventions on sleep in cancer patients: a meta-analysis of randomized controlled trials. J Clin Psychiatry. (2014) 75:1215–23. doi: 10.4088/JCP.13r08918
110. Wen Y, Yan Q, Pan Y, Gu X, Liu Y. Medical empirical research on forest bathing (Shinrin-yoku): a systematic review. Environ Health Prev Med. (2019) 24:70. doi: 10.1186/s12199-019-0822-8
111. Wang K, Liu S, Kong Z, Zhang Y, Liu J. Mind-body exercise (Wuqinxi) for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. Int J Environ Res Public Health. (2018) 16:72. doi: 10.3390/ijerph16010072
112. Capaldi CA, Dopko RL, Zelenski JM. The relationship between nature connectedness and happiness: a meta-analysis. Front Psychol. (2014) 5:976. doi: 10.3389/fpsyg.2014.00976
113. South EC, Hohl BC, Kondo MC, MacDonald JM, Branas CC. Effect of greening vacant land on mental health of community-dwelling adults: a cluster randomized trial. JAMA Netw Open. (2018) 1:e180298. doi: 10.1001/jamanetworkopen.2018.0298
114. Hansen MM, Jones R, Tocchini K. Shinrin-Yoku (forest bathing) and nature therapy: a state-of-the-art review. Int J Environ Res Public Health. (2017) 14:851. doi: 10.3390/ijerph14080851
115. Ideno Y, Hayashi K, Abe Y, Ueda K, Iso H, Noda M, et al. Blood pressure-lowering effect of Shinrin-yoku (Forest bathing): a systematic review and meta-analysis. BMC Complement Altern Med. (2017) 17:409. doi: 10.1186/s12906-017-1912-z
116. Peterfalvi A, Miko E, Nagy T, Reger B, Simon D, Miseta A, et al. Much more than a pleasant scent: a review on essential oils supporting the immune system. Molecules. (2019) 24:4530. doi: 10.3390/molecules24244530
117. Kiecolt-Glaser JK, Graham JE, Malarkey WB, Porter K, Lemeshow S, Glaser R. Olfactory influences on mood and autonomic, endocrine, and immune function. Psychoneuroendocrinology. (2008) 33:328–39. doi: 10.1016/j.psyneuen.2007.11.015
118. Reichling J, Schnitzler P, Suschke U, Saller R. Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties–an overview. Forsch Komplementmed. (2009) 16:79–90. doi: 10.1159/000207196
119. Bahrami T, Rejeh N, Heravi-Karimooi M, Vaismoradi M, Tadrisi SD, Sieloff CL. Aromatherapy massage versus reflexology on female elderly with acute coronary syndrome. Nurs Crit Care. (2018) 23:229–36. doi: 10.1111/nicc.12302
120. Karadag E, Samancioglu Baglama S. The effect of aromatherapy on fatigue and anxiety in patients undergoing hemodialysis treatment: a randomized controlled study. Holistic Nurs Pract. (2019) 33:222–9. doi: 10.1097/hnp.0000000000000334
121. Kang HJ, Nam ES, Lee Y, Kim M. How strong is the evidence for the anxiolytic efficacy of lavender? Systematic review and meta-analysis of randomized controlled trials. Asian Nurs Res. (2019) 13:295–305. doi: 10.1016/j.anr.2019.11.003
122. Gandhi GR, Vasconcelos ABS, Haran GH, Calisto V, Jothi G, Quintans JSS, et al. Essential oils and its bioactive compounds modulating cytokines: a systematic review on anti-asthmatic and immunomodulatory properties. Phytomedicine. (2019) 73:152854. doi: 10.1016/j.phymed.2019.152854
123. Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease. Physiol Rev. (2019) 99:1325–80. doi: 10.1152/physrev.00010.2018
124. Prather AA, Janicki-Deverts D, Hall MH, Cohen S. Behaviorally assessed sleep and susceptibility to the common cold. Sleep. (2015) 38:1353–9. doi: 10.5665/sleep.4968
125. Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. Sleep habits and susceptibility to the common cold. Arch Intern Med. (2009) 169:62–7. doi: 10.1001/archinternmed.2008.505
126. Hwang E, Shin S. The effects of aromatherapy on sleep improvement: a systematic literature review and meta-analysis. J Alternat Compl Med. (2015) 21:61–8. doi: 10.1089/acm.2014.0113
127. Zhou ES, Gardiner P, Bertisch SM. Integrative medicine for insomnia. Med Clin North Am. (2017) 101:865–79. doi: 10.1016/j.mcna.2017.04.005
128. Liu K, Chen Y, Wu D, Lin R, Wang Z, Pan L. Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract. (2020) 39:101132. doi: 10.1016/j.ctcp.2020.101132
129. Attia YA, Alagawany MM, Farag MR, Alkhatib FM, Khafaga AF, Abdel-Moneim A-ME, et al. Phytogenic products and phytochemicals as a candidate strategy to improve tolerance to coronavirus. Front Vet Sci. (2020) 7:573159. doi: 10.3389/fvets.2020.573159
130. Fan AY, Gu S, Alemi SF, Research Group for Evidence-based Chinese M. Chinese herbal medicine for COVID-19: current evidence with systematic review and meta-analysis. J Integr Med. (2020) 18:385–94. doi: 10.1016/j.joim.2020.07.008
131. Michaelis M, Doerr HW, Cinatl J Jr. Investigation of the influence of EPs® 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. (2011) 18:384–6. doi: 10.1016/j.phymed.2010.09.008
132. Neugebauer P, Mickenhagen A, Siefer O, Walger M. A new approach to pharmacological effects on ciliary beat frequency in cell cultures–exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine. (2005) 12:46–51. doi: 10.1016/j.phymed.2003.11.005
133. Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. (2013) CD006323. doi: 10.1002/14651858.CD006323.pub3
134. Schapowal A, Dobos G, Cramer H, Ong KC, Adler M, Zimmermann A, et al. Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis. Heliyon. (2019) 5:e02904. doi: 10.1016/j.heliyon.2019.e02904
135. Anheyer D, Cramer H, Lauche R, Saha FJ, Dobos G. Herbal medicine in children with respiratory tract infection: systematic review and meta-analysis. Acad Pediatr. (2018) 18:8–19. doi: 10.1016/j.acap.2017.06.006
136. Careddu D, Pettenazzo A. Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children. Int J Gen Med. (2018) 11:91–8. doi: 10.2147/ijgm.s154198
137. Porter RS, Bode RF. A review of the antiviral properties of black elder (Sambucus Nigra L.) products. Phytother Res. (2017) 31:533–54. doi: 10.1002/ptr.5782
138. Burge E, Mumcuoglu M, Simmons T. The effect of Sambucol on flu-like symptoms in chimpanzees: prophylactic and symptomdependent treatment. Int Zoo News. (1999) 46:16–9.
139. Zakay-Rones Z, Varsano N, Zlotnik M, Manor O, Regev L, Schlesinger M, et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Alternat Compl Med. (1995) 1:361–9. doi: 10.1089/acm.1995.1.361
140. Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. (2004) 32:132–40. doi: 10.1177/147323000403200205
141. Ide K, Kawasaki Y, Kawakami K, Yamada H. Anti-influenza virus effects of catechins: a molecular and clinical review. Curr Med Chem. (2016) 23:4773–83. doi: 10.2174/0929867324666161123091010
142. Raekiansyah M, Buerano CC, Luz MAD, Morita K. Inhibitory effect of the green tea molecule EGCG against dengue virus infection. Arch Virol. (2018) 163:1649–55. doi: 10.1007/s00705-018-3769-y
143. Furushima D, Ide K, Yamada H. Effect of tea catechins on influenza infection and the common cold with a focus on epidemiological/clinical studies. Molecules. (2018) 23:1795. doi: 10.3390/molecules23071795
144. Matsumoto K, Yamada H, Takuma N, Niino H, Sagesaka YM. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC Complement Altern Med. (2011) 11:15. doi: 10.1186/1472-6882-11-15
145. Ide K, Yamada H, Kawasaki Y. Effect of gargling with tea and ingredients of tea on the prevention of influenza infection: a meta-analysis. BMC Public Health. (2016) 16:396. doi: 10.1186/s12889-016-3083-0
146. Mousa HA. Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J Evid Based Complementary Altern Med. (2017) 22:166–74. doi: 10.1177/2156587216641831
147. Utsunomiya T, Kobayashi M, Pollard RB, Suzuki F. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother. (1997) 41:551–6.
148. Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OH. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res. (2009) 83:171–8. doi: 10.1016/j.antiviral.2009.04.012
149. Yoshino T, Arita R, Horiba Y, Watanabe K. The use of maoto (Ma-Huang-Tang), a traditional Japanese Kampo medicine, to alleviate flu symptoms: a systematic review and meta-analysis. BMC Complement Altern Med. (2019) 19:68. doi: 10.1186/s12906-019-2474-z
150. Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. (2014) 2:CD000530. doi: 10.1002/14651858.CD000530.pub3
151. Rauš K, Pleschka S, Klein P, Schoop R, Fisher P. Effect of an echinacea-based hot drink versus oseltamivir in influenza treatment: a randomized, double-blind, double-dummy, multicenter, noninferiority clinical trial. Curr Ther Res Clin Exp. (2015) 77:66–72. doi: 10.1016/j.curtheres.2015.04.001
152. Aucoin M, Cooley K, Saunders PR, Care J, Anheyer D, Medina DN, et al. The effect of Echinacea spp. on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: a rapid review. Adv Integr Med. (2020) 7:203–17. doi: 10.1016/j.aimed.2020.07.004
153. Droebner K, Ehrhardt C, Poetter A, Ludwig S, Planz O. CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice. Antiviral Res. (2007) 76:1–10. doi: 10.1016/j.antiviral.2007.04.001
154. Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, Poetter A, et al. A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res. (2007) 76:38–47. doi: 10.1016/j.antiviral.2007.05.002
155. Kalus U, Grigorov A, Kadecki O, Jansen JP, Kiesewetter H, Radtke H. Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract a prospective, randomised, placebo-controlled clinical study. Antiviral Res. (2009) 84:267–71. doi: 10.1016/j.antiviral.2009.10.001
156. Sexton M. Cannabis in the time of coronavirus disease 2019: the yin and yang of the endocannabinoid system in immunocompetence. J Alternat Compl Med. (2020) 26:444–8. doi: 10.1089/acm.2020.0144
157. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. (2020) 7:4. doi: 10.1186/s40779-020-0233-6
158. Chan KW, Wong VT, Tang SCW. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative chinese-western medicine for the management of 2019 novel coronavirus disease. Am J Chin Med. (2020) 48:737–62. doi: 10.1142/s0192415x20500378
159. López-Alcalde J, Yan Y, Witt CM, Barth J. Current state of research about Chinese Herbal Medicines (CHM) for the treatment of coronavirus disease 2019 (COVID-19): a scoping review. J Alternat Compl Med. (2020) 26:557–70. doi: 10.1089/acm.2020.0189
160. Puthiyedath R, Kataria S, Payyappallimana U, Mangalath P, Nampoothiri V, Sharma P, et al. Ayurvedic clinical profile of COVID-19 – a preliminary report. J Ayurveda Integrat Med. (2020). doi: 10.1016/j.jaim.2020.05.011. [Epub ahead of print].
161. Gannotta R, Malik S, Chan AY, Urgun K, Hsu F, Vadera S. Integrative medicine as a vital component of patient care. Cureus. (2018) 10:e3098. doi: 10.7759/cureus.3098
162. Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract. (2020) 40:101214. doi: 10.1016/j.ctcp.2020.101214
163. Li Y, Xu H, Lang H, Li J, Bi L, Li Y, et al. The efficacy and safety of Chinese traditional medicine injections on patients with coronavirus disease 2019: a protocol for systematic review and meta analysis. Medicine. (2020) 99:e21024. doi: 10.1097/MD.0000000000021024
164. Zhou M, Liang Q, Pei Q, Xu F, Wen H. Chinese medicine for coronavirus disease 2019 as complementary therapy: a protocol for a systematic review and meta-analysis. Medicine. (2020) 99:e21034. doi: 10.1097/MD.0000000000021034
165. Huang J, Wu L, Ren X, Wu X, Chen Y, Ran G, et al. Traditional Chinese medicine for corona virus disease 2019: a protocol for systematic review. Medicine. (2020) 99:e21774. doi: 10.1097/MD.0000000000021774
166. Huang S, Wang S, Li G, Wang M, Yu W, Shao G, et al. Efficacy and safety of acupuncture therapy for asymptomatic infection of COVID-19: a protocol for systematic review and meta-analysis. Medicine. (2020) 99:e22697. doi: 10.1097/MD.0000000000022697
167. Peng J, Wu Z, Zhong H, Zhou Y, Wang L, Wang Y, et al. The effect of qigong for pulmonary function and quality of life in patients with covid-19: a protocol for systematic review and meta-analysis. Medicine. (2020) 99:e22041. doi: 10.1097/MD.0000000000022041
168. Altherr S. Aktuelle Artenschutzprobleme im Kontext der traditionellen chinesischen Medizin. Chin Med. (2020) 35:113–28. doi: 10.1007/s00052-020-0271-x
169. Standing Committee of the National People's Congress (SCNPC). Decisions Relating to a Total Prohibition on Illegal Wildlife Trade, Eliminating the Bad Habit of Excessive Eating of Wildlife, and Effectively Safeguarding the Lives and Health of the Public. (2020). Available online at: https://eia-international.org/wp-content/uploads/Decisions-of-the-Standing-Committee-of-the-National-People%E2%80%99s-Congress-24-February-2020.pdf
170. Alberts E. China Releases List of Animals to Be Farmed After Covid-19. (2020). Available online at: https://news.mongabay.com/2020/04/china-releases-list-of-animals-to-be-farmed-after-covid-19/
171. Manohar R, Kessler CS. Ayurveda's contributions to vegetarian nutrition in medicine. Forsch Komplementmed. (2016) 23:89–94. doi: 10.1159/000445400
172. Noone C, McSharry J, Smalle M, Burns A, Dwan K, Devane D, et al. Video calls for reducing social isolation and loneliness in older people: a rapid review. Cochrane Database Syst Rev. (2020) 5:CD013632. doi: 10.1002/14651858.CD013632
173. Baars EW, Zoen EB, Breitkreuz T, Martin D, Matthes H, von Schoen-Angerer T, et al. The contribution of complementary and alternative medicine to reduce antibiotic use: a narrative review of health concepts, prevention, and treatment strategies. Evidence-based complementary and alternative medicine. eCAM. (2019) 2019:5365608. doi: 10.1155/2019/5365608
174. Zhang J, Xie B, Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behavior Immunity. (2020) 87:59–73. doi: 10.1016/j.bbi.2020.04.046
175. Kirby T. Australian Government releases face masks to protect against coronavirus. Lancet Resp Med. (2020) 8:239. doi: 10.1016/s2213-2600(20)30064-3
176. Boretti A, Banik BK. Intravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome. PharmaNutrition. (2020) 12:100190. doi: 10.1016/j.phanu.2020.100190
177. Kok CR, Hutkins R. Yogurt and other fermented foods as sources of health-promoting bacteria. Nutr Rev. (2018) 76(Suppl. 1):4–15. doi: 10.1093/nutrit/nuy056
178. Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, et al. Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Zhejiang da Xue Xue Bao Yi xue Ban. (2020) 49:147–57.
179. Yamamoto Y, Saruta J, Takahashi T, To M, Shimizu T, Hayashi T, et al. Effect of ingesting yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on influenza virus-bound salivary IgA in elderly residents of nursing homes: a randomized controlled trial. Acta Odontol Scand. (2019) 77:517–24. doi: 10.1080/00016357.2019.1609697
Keywords: COVID-19, integrative medicine, complementary medicine, SARS-CoV-2, traditional medicine systems, phytomedicine, botanicals, mind-body medicine
Citation: Seifert G, Jeitler M, Stange R, Michalsen A, Cramer H, Brinkhaus B, Esch T, Kerckhoff A, Paul A, Teut M, Ghadjar P, Langhorst J, Häupl T, Murthy V and Kessler CS (2020) The Relevance of Complementary and Integrative Medicine in the COVID-19 Pandemic: A Qualitative Review of the Literature. Front. Med. 7:587749. doi: 10.3389/fmed.2020.587749
Received: 27 July 2020; Accepted: 17 November 2020;
Published: 11 December 2020.
Edited by:
Kuldeep Dhama, Indian Veterinary Research Institute (IVRI), IndiaReviewed by:
Khan Sharun, Indian Veterinary Research Institute (IVRI), IndiaTalha Bin Emran, Begum Gulchemonara Trust University, Bangladesh
Youssef A. Attia, King Abdulaziz University, Saudi Arabia
Maimoona Qindeel, Quaid-i-Azam University Islamabad, Pakistan
Copyright © 2020 Seifert, Jeitler, Stange, Michalsen, Cramer, Brinkhaus, Esch, Kerckhoff, Paul, Teut, Ghadjar, Langhorst, Häupl, Murthy and Kessler. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Georg Seifert, georg.seifert@charite.de
†These authors have contributed equally to this work